A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy. Led by Ludwig Princeton's Asael Roichman and Branch Director Joshua ...

A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called VIR-5500, is a "masked T-cell engager." This type of immunotherapy ignites our own ...

A recent study found that just 10 minutes of vigorous activity could hinder cancer progression. The study shows that short, high-intensity workouts can help to alter the molecular profile of the ...

Rx for Resilience: Curing Burnout in Oncology Through Smarter Workflows and Supportive Practices The review by Hazim et al 1 in this journal outlines ongoing and planned major clinical trials in ...

Gero, a biotechnology company developing novel therapeutics for aging and chronic diseases, has released ProtoBind-Diff, a novel masked diffusion language model that generates drug-like molecules for ...

Innovative technologies such as artificial intelligence (AI), machine learning, and quantum computing can accelerate the design and discovery of novel drugs to fight cancer. A new peer-reviewed study ...

This hands-on course teaches step-by-step techniques for interpreting mass spectrometric data to identify molecular structures. Participants will learn elemental composition analysis, tandem MS ...

Scientists have long been fascinated by tiny molecules called polyamines. These molecules exist in every living cell, from simple bacteria to human beings. They help cells grow, divide, and carry out ...

A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell clusters called tertiary lymphoid structures (TLSs) in response to foreign ...